Thomas Malley, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), bought 9,968 shares at $12.50 ($125K) on 2012-06-08, disclosed to the SEC on 2012-06-11.
Open-market purchase of $125k PBYI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 1,800 | $23K | 18.1% |
| 2 | $12.50 | 8,168 | $102K | 81.9% |
| Total | $12.50 avg | 9,968 | $125K | 100% |
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |